Showing results (1381-1390 of 2,506) with videos related to
Sort By:
Pageof 251
Journal of Diabetes Investigation|May 30, 2020
Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody-positive by bridging-type enzyme-linked immunosorbent assayEiji Kawasaki, Takahiro Fukuyama, Aira Uchida, et al.Journal of Diabetes Investigation|August 7, 2018
Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort studyXiang Li, Zhangrong Xu, Linong Ji, et al.Journal of Diabetes Investigation|August 13, 2018
Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug developmentBo AhrénJournal of Diabetes Investigation|August 13, 2018
Verification of Kumamoto Declaration 2013 and Glycemic Targets for Elderly Patients with Diabetes in Japan for prevention of diabetic complications: A retrospective longitudinal study using outpatient clinical dataShuhei Nakanishi, Hidenori Hirukawa, Masashi Shimoda, et al.Journal of Diabetes Investigation|August 3, 2018
Dietary survey in Japanese patients with type 2 diabetes and the influence of dietary carbohydrate on glycated hemoglobin: The Sleep and Food Registry in Kanagawa studyTadashi Yamakawa, Rika Sakamoto, Kenichiro Takahashi, et al.Journal of Diabetes Investigation|May 19, 2017
Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five casesSatoshi Yoshiji, Takaaki Murakami, Shin-Ichi Harashima, et al.Journal of Diabetes Investigation|May 27, 2018
Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosisMads Svart, Nikolaj Rittig, Niels Møller, et al.Journal of Diabetes Investigation|May 18, 2018
How does glucagon-like peptide 1 stimulate human β-cell proliferation? A lesson from islet graft experimentsYoshio FujitaniJournal of Diabetes Investigation|April 3, 2018
Efficacy and safety of the G protein-coupled receptor 119 agonist DS-8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo-controlled studyYasuo Terauchi, Yuichiro Yamada, Hirotaka Watada, et al.Journal of Diabetes Investigation|May 20, 2018
Serum high-density lipoprotein cholesterol is a protective predictor of executive function in older patients with diabetes mellitusYue Sun, Jenny Lee, Ronald C Ma, et al.Pageof 251